DURECT Corporation to Participate in Upcoming Healthcare Conferences
* Reuters is not responsible for the content in this press release.
CUPERTINO, Calif., June 6 /PRNewswire-FirstCall/ -- DURECT Corporation
(Nasdaq: DRRX) announced today that management is scheduled to present at
three upcoming life sciences conferences in New York, NY. -- Needham &
Company's Biotechnology and Medical Technology Conference on
Thursday, June 12th at 11:30 a.m. EDT.
-- Leerink Swann's Pain Roundtable Conference, on Monday, June 23rd at
12:45 p.m. EDT.
-- Jefferies' 2nd Annual Healthcare Conference on Thursday, June 26th at
10:45 a.m. EDT.
A live audio webcast of the presentations will be available by accessing
DURECT's homepage at http://www.durect.com and clicking "Investor Relations."
If you are unable to participate during the live webcast, the call will be
archived on DURECT's website under Audio Archive in the "Investor Relations"
section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit
http://www.durect.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)
SOURCE DURECT Corporation
Matthew J. Hogan, Chief Financial Officer of DURECT Corporation,
+1-408-777-4936
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters